Published on European Cystic Fibrosis Society (ECFS) (https://www.ecfs.eu)

Home > Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis.

Use of hyperpolarized helium-3 MRI to assess response to ivacaftor treatment in patients with cystic fibrosis.

Resource Type

CF Research News

Authors

Altes TA, Johnson M, Fidler M, Botfield M, Tustison NJ, Leiva-Salinas C, de Lange EE, Froh D, Mugler JP 3rd

References

J Cyst Fibros. 2017 Jan 26. pii: S1569-1993(16)30673-7.

Document

PDF icon CF Research News article [1]

Link

Scientific abstract [2]

Keywords

cystic fibrosis transmembrane conductance regulator modulator [3]
forced expiratory volume [4]
Pulmonary [5]

Date

Thursday, January 26, 2017

Featured resource article

Yes

Resource - Guideline Type

Other Guidelines [6]
Source URL:https://www.ecfs.eu/resource-article/cf-research-news/use-hyperpolarized-helium-3-mri-assess-response-ivacaftor

Links
[1] https://www.ecfs.eu/sites/default/files/cf-research-article-files/JCF-D-16-00232R2_FINAL_Altest_26012017_0.pdf [2] https://www.ncbi.nlm.nih.gov/pubmed/?term=USE%20OF%20HYPERPOLARIZED%20HELIUM-3%20MRI%20TO%20ASSESS%20RESPONSE%20TO%20IVACAFTOR%20TREATMENT%20IN%20PATIENTS%20WITH%20CYSTIC%20FIBROSIS [3] https://www.ecfs.eu/research-article-keywords/cystic-fibrosis-transmembrane-conductance-regulator-modulator [4] https://www.ecfs.eu/research-article-keywords/forced-expiratory-volume [5] https://www.ecfs.eu/research-article-keywords/pulmonary [6] https://www.ecfs.eu/resource-guideline-type/other-guidelines